Hepatitis, Alcoholic clinical trials
The registry lists 113 studies for Hepatitis, Alcoholic across more than 10 countries. 24 are recruiting or about to start. 92 of them are mainly about Hepatitis, Alcoholic (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27.
Get an email when these change. Save the Hepatitis, Alcoholic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Institute of Liver and Biliary Sciences, India (9) · University Hospital, Lille (6) · Post Graduate Institute of Medical Education and Research, Chandigarh (5) · University of Aarhus (5) · Indiana University (4) · Erasme University Hospital (3) · Dayanand Medical College and Hospital (3) · Vital Therapies, Inc. (3)
What is being tested here
Drugs under test in Hepatitis, Alcoholic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Corticosteroids 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3, phase 3 first
- Nov 2027Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) · Phase 3 · Bausch Health Americas, Inc.
- Apr 2027Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease · University Hospital, Lille
- Jun 2027Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH · Johns Hopkins University
Who these studies take
Of the 17 Hepatitis, Alcoholic studies recruiting now, 9 (53%) set no upper age limit and 8 (47%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (12%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 15 (88%) | 15 (88%) |
| 30 | 17 (100%) | 17 (100%) |
| 40 | 17 (100%) | 17 (100%) |
| 50 | 17 (100%) | 17 (100%) |
| 65 | 16 (94%) | 16 (94%) |
| 75 | 14 (82%) | 14 (82%) |
| 85 | 9 (53%) | 9 (53%) |
Across all 113 studies, recruiting or not: 50% stop at 75 or younger and 15% at 65; 2% take children; 0% are for women only and 3% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Hepatitis, Alcoholic studies take
Of 16 interventional studies with no phase under Hepatitis, Alcoholic, half reached primary completion within 39 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 39 mo24–51 · 16 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
- Bovine Colostrum In The Treatment Of Severe Alcohol-Associated HepatitisOct 27, 2026NCT07898761
Studies
Recruiting first, then most recently updated. Showing 50 of 113. Browse all 113 → or search them.
- Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)RecruitingNCT07428538Phase 31 country
- Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic HepatitisRecruitingNCT040883701 country
- HA35 Moderate Alcoholic Hepatitis (AH) StudyRecruitingNCT05018481Early Phase 11 country
- A-TANGO Phase 2 StudyRecruitingNCT06890039Phase 21 country
- Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver DiseaseRecruitingNCT070605471 country
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAHRecruitingNCT03845205Not applicable1 country
- PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic HepatitisRecruitingNCT06956482Phase 31 country
- Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver DiseaseRecruitingNCT041065181 country
- Intra-Hepatic Microbiota in Alcoholic HepatitisRecruitingNCT063079641 country
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling by invitationNCT042341391 country
- Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HPRecruitingNCT072625151 country
- LiverTREM-1: Hepatic TREM-1 Expression and Prognosis in Severe Alcoholic HepatitisNot yet recruitingNCT07176741
- Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis PatientsRecruitingNCT06159244Not applicable1 country
- Recompensation in Alcohol Related HepatitisRecruitingNCT06740318Not applicable1 country
- Faecal Microbiota Transplantation for Liver CirrhosisRecruitingNCT04932577Phase 2/31 country
- Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic HepatitisNot yet recruitingNCT06789315Not applicable1 country
- Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic HepatitisRecruitingNCT05006430Phase 1/21 country
- Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant FunctionRecruitingNCT06355726Not applicable1 country
- Nutritional Interventions in Patients With Alcohol-associated HepatitisNot yet recruitingNCT06131177Not applicable
- Complex Exploratory Study of Alcohol-Associated HepatitisNot yet recruitingNCT063581961 country
- MRG-001 in Patients With Alcoholic HepatitisNot yet recruitingNCT06307522Phase 2
- Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic HepatitisNot yet recruitingNCT06155760Not applicable1 country
- BActeriophages To Treat Liver Disease Eliminating Harmful Bacteria (BATTLE)RecruitingNCT056184181 country
- N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic HepatitisRecruitingNCT03069300Phase 31 country
- Bovine Colostrum In The Treatment Of Severe Alcohol-Associated HepatitisCompletedNCT07898761Phase 31 country
- Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)CompletedNCT05294744Not applicable1 country
- Alcohol Consumption and Plasma cfDNA Methylation in Chronic Hepatitis BCompletedNCT078655201 country
- Short Course Steroids in Alcohol Associated HepatitisCompletedNCT06919458Phase 31 country
- Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use DisordersCompletedNCT05375682Not applicable1 country
- Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled TrialActive, not recruitingNCT02473341Phase 31 country
- Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsCompletedNCT023446801 country
- Chronic Hepatitis B Virus Infection in ZambiaCompletedNCT031588181 country
- Outcomes Using MARS for Patients With ALFCompletedNCT055949531 country
- A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)CompletedNCT06685692Phase 21 country
- FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) StudyTerminatedNCT05639543Phase 23 countries
- Trial for Hepatocellular Carcinoma Adjuvant Treatment by LipiocisCompletedNCT00116454Phase 31 country
- Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian AdultsCompletedNCT031496271 country
- Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With PrednisoloneCompletedNCT02281929Phase 31 country
- Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical TreatmentCompletedNCT01756794Not applicable2 countries
- A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic HepatitisCompletedNCT01903798Phase 21 country
- IL-1 Signal Inhibition in Alcoholic HepatitisCompletedNCT03775109Phase 21 country
- Alcoholic Hepatitis Network Observational StudyCompletedNCT038508991 country
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic HepatitisCompletedNCT04072822Phase 21 country
- A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03432260Phase 21 country
- A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 TreatmentCompletedNCT04563026Phase 26 countries
- DUR-928 in Patients With Alcoholic HepatitisCompletedNCT03917407Phase 21 country
- Vitamin C Infusion for TReatment in Sepsis and Alcoholic HepatitisCompletedNCT03829683Phase 21 country
- Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.CompletedNCT058838911 country
- Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic HepatitisCompletedNCT03732586Not applicable1 country
- Changes in gUt micRobiota After Enteral Feeding (in Alcoholic Hepatitis)CompletedNCT045440201 country